Height Securities Highlights Senate Committee Set To Meet Today On FDA User Fee Agreement Reauthorization, Thinks It Highly Likely Amendments Will Be Introduced To 'Materially Impact' Cost Of Drugs, But Unlikely Amendments Will Receive Necessary Votes